Reversing Alzheimers http://reversingalzheimers.org Sat, 29 Jan 2011 03:06:02 +0000 en hourly 1 http://wordpress.org/?v=3.0.4 ReversingAlzheimershttp://feedburner.google.com Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers http://reversingalzheimers.org/open-label-extension-study-of-rosiglitazone-xr-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimers.htm http://reversingalzheimers.org/open-label-extension-study-of-rosiglitazone-xr-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimers.htm#comments Sat, 29 Jan 2011 03:06:02 +0000 lowes1 http://reversingalzheimers.org/open-label-extension-study-of-rosiglitazone-xr-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimers.htm

Conditions:   Alzheimer’s Disease;   Mild-to-moderate Alzheimers Disease
Intervention:   Drug: Rosiglitazone XR
Sponsor:   GlaxoSmithKline
Terminated – verified November 2010 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/open-label-extension-study-of-rosiglitazone-xr-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimers.htm/feed 0 Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer’s Disease http://reversingalzheimers.org/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimers-disease.htm http://reversingalzheimers.org/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimers-disease.htm#comments Fri, 28 Jan 2011 22:46:04 +0000 lowes1 http://reversingalzheimers.org/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimers-disease.htm

Conditions:   Alzheimer’s Disease;   Mild Cognitive Impairment
Interventions:   Other: Gastro-retentive zinc cysteine tablet;   Other: Tablet identical physically to active comparator containing some lactose
Sponsor:   Adeona Pharmaceuticals
Active, not recruiting – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/trial-of-novel-oral-zinc-cysteine-preparation-in-alzheimers-disease.htm/feed 0 Evaluation of a Diet in Patients With Senile Dementia http://reversingalzheimers.org/evaluation-of-a-diet-in-patients-with-senile-dementia.htm http://reversingalzheimers.org/evaluation-of-a-diet-in-patients-with-senile-dementia.htm#comments Fri, 28 Jan 2011 18:53:14 +0000 lowes1 http://reversingalzheimers.org/evaluation-of-a-diet-in-patients-with-senile-dementia.htm

Conditions:   Alzheimer’s Disease;   Parkinson’s Disease;   Senile Dementia
Interventions:   Dietary Supplement: Supressi. T-Diet plus Range;   Dietary Supplement: High Protein. T-Diet plus Range
Sponsor:   Vegenat, S.A.
Recruiting – verified October 2010 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/evaluation-of-a-diet-in-patients-with-senile-dementia.htm/feed 0 Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly With: Memory Complaint, Mild Alzheimer’s Disease, and Cognitively Normal http://reversingalzheimers.org/effect-of-egb761%c2%ae-on-brain-glucose-metabolism-in-three-groups-of-elderly-with-memory-complaint-mild-alzheimers-disease-and-cognitively-normal.htm http://reversingalzheimers.org/effect-of-egb761%c2%ae-on-brain-glucose-metabolism-in-three-groups-of-elderly-with-memory-complaint-mild-alzheimers-disease-and-cognitively-normal.htm#comments Thu, 27 Jan 2011 22:30:41 +0000 lowes1 http://reversingalzheimers.org/effect-of-egb761%c2%ae-on-brain-glucose-metabolism-in-three-groups-of-elderly-with-memory-complaint-mild-alzheimers-disease-and-cognitively-normal.htm

Conditions:   Alzheimer’s Disease;   Cognitive Impairment
Interventions:   Drug: EGb761®;   Drug: Placebo
Sponsor:   Ipsen
Recruiting – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/effect-of-egb761%c2%ae-on-brain-glucose-metabolism-in-three-groups-of-elderly-with-memory-complaint-mild-alzheimers-disease-and-cognitively-normal.htm/feed 0 Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer’s Disease http://reversingalzheimers.org/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimers-disease.htm http://reversingalzheimers.org/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimers-disease.htm#comments Thu, 27 Jan 2011 19:07:37 +0000 lowes1 http://reversingalzheimers.org/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimers-disease.htm

Condition:   Alzheimer’s Disease
Intervention:   Biological: ACC-001 (vanutide cridificar)
Sponsors:   JANSSEN Alzheimer Immunotherapy Research & Development, LLC;   Pfizer
Not yet recruiting – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimers-disease.htm/feed 0 Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer’s Disease http://reversingalzheimers.org/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimers-disease.htm http://reversingalzheimers.org/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimers-disease.htm#comments Tue, 25 Jan 2011 17:09:54 +0000 lowes1 http://reversingalzheimers.org/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimers-disease.htm

Condition:   Alzheimer’s Disease
Interventions:   Drug: Huperzine A;   Drug: huperzine A;   Drug: Placebo
Sponsor:   Shandong Luye Pharmaceutical Co., Ltd.
Recruiting – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/study-of-huperzine-a-sustained-release-tablets-in-patients-with-alzheimers-disease.htm/feed 0 A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer’s Disease http://reversingalzheimers.org/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimers-disease.htm http://reversingalzheimers.org/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimers-disease.htm#comments Tue, 25 Jan 2011 03:47:04 +0000 lowes1 http://reversingalzheimers.org/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimers-disease.htm

Conditions:   Alzheimer Disease;   Dementia;   Mental Disorders;   Brain Diseases
Intervention:   Drug: galantamine hydrobromide
Sponsor:   Janssen-Cilag S.p.A.
Completed – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/a-study-of-the-safety-and-effectiveness-of-galantamine-in-patients-with-alzheimers-disease.htm/feed 0 The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type http://reversingalzheimers.org/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type.htm http://reversingalzheimers.org/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type.htm#comments Mon, 24 Jan 2011 23:35:08 +0000 lowes1 http://reversingalzheimers.org/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type.htm

Condition:   Alzheimer Disease
Intervention:   Drug: galantamine hydrobromide
Sponsor:   Janssen Korea, Ltd., Korea
Completed – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/the-efficacy-of-galantamine-on-the-attention-and-the-frontal-function-of-the-patients-with-dementia-of-alzheimer-type.htm/feed 0 Long-term Safety and Efficacy of Galantamine in Alzheimer’s Disease http://reversingalzheimers.org/long-term-safety-and-efficacy-of-galantamine-in-alzheimers-disease.htm http://reversingalzheimers.org/long-term-safety-and-efficacy-of-galantamine-in-alzheimers-disease.htm#comments Mon, 24 Jan 2011 19:31:31 +0000 lowes1 http://reversingalzheimers.org/long-term-safety-and-efficacy-of-galantamine-in-alzheimers-disease.htm

Condition:   Alzheimer Disease
Intervention:   Drug: galantamine
Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/long-term-safety-and-efficacy-of-galantamine-in-alzheimers-disease.htm/feed 0 A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer’s Disease. http://reversingalzheimers.org/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimers-disease.htm http://reversingalzheimers.org/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimers-disease.htm#comments Mon, 24 Jan 2011 15:27:10 +0000 lowes1 http://reversingalzheimers.org/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimers-disease.htm

Condition:   Alzheimer’s Disease
Intervention:   Drug: galantamine
Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed – verified January 2011 View full post on ClinicalTrials.gov: “Alzheimer Disease” | updated in the last 30 days

]]> http://reversingalzheimers.org/a-cardiac-safety-study-of-galantamine-in-the-treatment-of-alzheimers-disease.htm/feed 0